Literature DB >> 15927187

Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing.

Zhi-Yan Li1, Guo-Bing Xu, Tie-An Xia.   

Abstract

The metabolic syndrome (MS) was a clustering of some cardiovascular risk factors, including hypertriglyceridemia, obesity, insulin resistance, glucose intolerance and hypertension. MS patients are at a risk of cardiovascular morbidity and mortality. Although the prevalence of MS in variety of ethnic group has been well documented, limited information is available about the prevalence in Chinese population. The aim of this study is to investigate the prevalence of the MS and dyslipidemia among 16,342 subjects (8801 males and 7541 females) aged 20-90 years in Beijing. 51.9% males and 40.8% females had at least one abnormal serum lipid concentration. The age-standardized prevalence of MS was 13.2% according to Chinese Diabetes Society (CDS) definition of the MS. The prevalence increased with age in both genders. MS was more commonly seen in males than in females (15.7% versus 10.2%). According to the diagnostic criterion, dyslipidemia was observed in 51.9% of males and 40.8% of females, and there was obvious difference between them (P < 0.001). This report on the MS and dyslipidemia from Beijing professional population showed a high prevalence of these disorders. Efforts on promoting healthy diets and physical activity in China should be undertaken.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927187     DOI: 10.1016/j.atherosclerosis.2005.03.033

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese.

Authors:  Qing Zhang; Shanshan Lou; Zhaowei Meng; Xiaojun Ren
Journal:  Clin Rheumatol       Date:  2010-12-22       Impact factor: 2.980

2.  The metabolic syndrome in China.

Authors:  Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

3.  Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study.

Authors:  X Q Lao; G Neil Thomas; C Q Jiang; W S Zhang; P Yin; P Adab; T H Lam; K K Cheng
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 4.  Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians.

Authors:  Kai-Hang Yiu; Hung-Fat Tse; Mo-Yin Mok; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

5.  Expressions of interleukin-1β and interleukin-6 within aortas and uteri of rats with various severities of ligature-induced periodontitis.

Authors:  Shouzhi Ma; Jianbin Guo; Xiaoqing You; Wen Xia; Fuhua Yan
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

6.  Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors.

Authors:  Yuan-Yuan Qin; Peng Wang; Jin-Qiu Qin; Ai-Qiu Wei; Ping Huang; Zhan-Feng Lai; Fa-Quan Lin
Journal:  J Clin Lab Anal       Date:  2017-04-10       Impact factor: 2.352

7.  Environmental tobacco use and indicators of metabolic syndrome in Chinese adults.

Authors:  Bin Xie; Paula H Palmer; Zengchang Pang; Ping Sun; Haiping Duan; C Anderson Johnson
Journal:  Nicotine Tob Res       Date:  2010-01-07       Impact factor: 4.244

8.  Prevalence of the metabolic syndrome among rural original adults in NingXia, China.

Authors:  Zhao Yi; Jin Jing; Liu Xiu-ying; Xu Hongxia; Yang Jianjun; Zhang Yuhong
Journal:  BMC Public Health       Date:  2010-03-17       Impact factor: 3.295

9.  Comprehensive assessment of metabolic syndrome among rural Bangladeshi women.

Authors:  Subrina Jesmin; Md Reazul Islam; A M Shahidul Islam; Md Sohag Mia; Sayeeda Nusrat Sultana; Sohel Zaedi; Naoto Yamaguchi; Yoshio Iwashima; Michiaki Hiroe; Tetsu Watanabe
Journal:  BMC Public Health       Date:  2012-01-19       Impact factor: 3.295

10.  Risk factors of non-communicable diseases and metabolic syndrome.

Authors:  N Esmailnasab; G Moradi; A Delaveri
Journal:  Iran J Public Health       Date:  2012-07-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.